Fidson Healthcare pre-tax profit rises 49.5% to N17.79 billion in 9 months
AI Executive Briefing
Gemini Flash AI~45s readFidson Healthcare Plc achieved a strong financial performance for the nine months ended September 30, 2026, with pre-tax profit rising 49.47% to N17.79 billion. This growth was largely attributed to improved operating margins and a significant reduction in foreign exchange losses compared to the previous year.
Context & Background
- ✦The company navigated a challenging economic environment by reducing finance costs and leveraging a successful rights issue to strengthen its balance sheet.
- ✦Despite the profit growth, the company saw a substantial increase in administrative and distribution expenses, alongside a 70.30% rise in total borrowings.
Key Figures & Named Entities
Fidson Healthcare Plc:Reported N112.61 billion in revenue and N11.74 billion in profit after tax.N104.28 million:The amount of net exchange losses recorded for the nine-month period, down from N4.16 billion.
Outlook & Next Steps
The company must focus on managing its rising inventory and trade receivables while balancing its increased debt obligations to sustain earnings growth through the final quarter of 2026.
Key Takeaways
AI Summary- Fidson Healthcare Plc reported a 49.47% increase in nine-month pre-tax profit to N17.79 billion, driven by a significant reduction in foreign exchange losses.
- The company's nine-month pre-tax profit has already surpassed the total N14.96 billion profit recorded for the entire 2025 financial year.
- Shareholders' funds nearly doubled to N60.01 billion, bolstered by a successful rights issue that raised N21.36 billion.
Key Facts:September 30, 2026: Fidson Healthcare recorded a pre-tax profit of N17.79 billion for the nine months ended September 30, 2026.October 27, 2026: Fidson's share price gained approximately 66.7% year-to-date by the close of trading on October 27, 2026.
Editorial Excerpt
Fidson Healthcare Plc recorded a 49.47% increase in pre-tax profit to N17.79 billion for the nine months ended September 30, 2026, compared with N11.90 billion in the corresponding period of 2025, as foreign exchange losses declined sharply.
Frequently Asked Questions About This Story
What was the primary driver behind Fidson Healthcare's profit growth in the first nine months of 2026?
The growth was primarily supported by lower financing costs and a sharp decline in net exchange losses, which fell to N104.28 million from N4.16 billion in the previous year.
How did the company's revenue perform across its different product categories?
Ethical products grew by 13.17% to N69.19 billion, Over-the-counter products rose by 26.01% to N35.05 billion, and consumer healthcare revenue increased by 69.77% to N6.39 billion.
